Skip to content
Research Article Open access CC BY 4.0

Drug Permeation across the Blood-Brain Barrier: Applications of Nanotechnology

Marc Fakhoury, Ryusuke Takechi, Hani Al-Salami

Journal of Advances in Medicine and Medical Research · pp. 547–556 · Published 31 Dec 2014

10.9734/BJMMR/2015/15493

Abstract

The blood-brain barrier (BBB) is a neurobiological frontier that isolates brain tissues from the blood vascular system. Its main role is to protect the brain and the central nervous system from external fluctuations in hormones, nutrients and drugs, while allowing the passage of water and small lipophilic molecules. Diffusion across the BBB can occur through several biological mechanisms, but the most common one is simple diffusion, which mainly depends on the size, lipid solubility and concentration gradient of the molecule. Because of the highly dense network of capillary endothelium cells found in the BBB, most of the drugs are not able to cross this physiological barrier. Delivering therapeutic agents to the brain is thus a big challenge, which may prevent treatment of important neurological diseases. In order to overcome this difficulty, researchers have used nanotechnology to help the passage of drugs across the BBB. Nanotechnology has significantly contributed to the field of biotechnology by improving the strategies for drug delivery, and by providing novel carriers for safe and effective brain targeting. The aim of this review is to discuss in more details the anatomical structure and the functions of the BBB, as well as its significance in neurological diseases. A closer look will be given at the transport mechanisms across the BBB. This review finally explores the most recent advances in the field of nanotechnology for drug delivery in the brain, and gives meaningful examples of delivery systems developed including the micelles, liposomes, dendrimers, microcapsules and polymeric nanoparticles.

Blood-brain barrier drug delivery nanotechnology neurological disease

Cited by 25

Nanotechnology-based drug delivery for the treatment of CNS disorders

Khushi R. Mittal, Nandini Pharasi, Bhavya Sarna · Translational Neuroscience · 2022

Curcumin and Its Derivatives as Theranostic Agents in Alzheimer’s Disease: The Implication of Nanotechnology

Umair Shabbir, Momna Rubab, Akanksha Tyagi · International Journal of Molecular Sciences · 2020

Crossing the blood–brain barrier: nanoparticle-based strategies for neurodegenerative disease therapy

Elena Haro-Martínez, Elena Muscolino, Núria Moral · Drug Delivery and Translational Research · 2025

Nanomedical drug delivery for neurodegenerative disease

Navjot Kaur, Vanktesh Kumar, Thatikayala Mahender · Nanomedical Drug Delivery for Neurodegenerative Diseases · 2022

Drug delivery approaches for the treatment of glioblastoma multiforme

Marc Fakhoury · Artificial Cells, Nanomedicine, and Biotechnology · 2015

Nano-Based Vaccine Delivery Systems: Innovative Therapeutics Against Cancer and Neurological Disorders

Sarfraz Ahmed, David Gozal, Abdelnaby Khalyfa · International Journal of Molecular Sciences · 2025

Immune-mediated processes in neurodegeneration: where do we stand?

Marc Fakhoury · Journal of Neurology · 2016

Showing 20 of 25 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

25

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.